 |
 |

Subthalamic Stimulation in Parkinson Disease
Intraoperative Predictive Factors
Jean-Luc Houeto, MD;
Marie-Laure Welter, MD;
Paul-Boulos Bejjani, MD;
Sophie Tezenas du Montcel, MD;
Anne-Marie Bonnet, MD;
Valerie Mesnage, MD;
Soledad Navarro, MD;
Bernard Pidoux, MD, PhD;
Didier Dormont, MD;
Philippe Cornu, MD;
Yves Agid, MD, PhD
Arch Neurol. 2003;60:690-694.
Background High-frequency stimulation of the subthalamic nucleus (STN) is an effective treatment for advanced forms of Parkinson disease. Postoperative improvement of motor parkinsonian disability is known to depend on patient selection and surgical targeting.
Objective To determine which clinical and electrophysiological variables evaluated during the operation predict the postoperative clinical outcome of patients with Parkinson disease treated by bilateral high-frequency stimulation of the STN.
Methods Intraoperative clinical and electrophysiological data obtained in 41 patients with Parkinson disease who underwent bilateral implantation of electrodes for STN stimulation were correlated with the improvement in parkinsonian disability assessed 6 months after the operation.
Results The extent of STN neuronal activity recorded along the trajectory of the therapeutic electrode had no effect on the postoperative clinical outcome. The intraoperative improvement in segmental akinesia, but not rigidity, was predictive of the postoperative improvement in parkinsonian motor disability and reduction in daily levodopa-equivalent dosage. Parkinsonian motor disability scores assessed after surgery were lower in patients with intraoperative stimulation-induced dyskinesias than in those without stimulation-induced dyskinesias.
Conclusion The improvement of segmental akinesia and the observation of dyskinesias provoked by stimulation during the operation predict the best postoperative effects of bilateral STN stimulation on parkinsonian motor disability.
From the Centre d'Investigation Clinique, Fédération de Neurologie, INSERM Unit 289 (Drs Houeto, Welter, Bonnet, Mesnage, and Agid), and Services de Biostatistique (Dr Tezenas du Montcel), Neuroradiologie (Dr Dormont), and Neurochirurgie (Drs Navarro and Cornu), and Fédération de Neurophysiologie Clinique (Dr Pidoux), Hôpital de la Salpêtrière, Paris, France; and Hospital Notre Dame des Secours, Byblos-Jbeil, Lebanon (Dr Bejjani).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus
Tommasi et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:813-819.
ABSTRACT
| FULL TEXT
Subthalamic Nucleus Stimulation: Improvements in Outcome With Reprogramming
Moro et al.
Arch Neurol 2006;63:1266-1272.
ABSTRACT
| FULL TEXT
Subthalamic Stimulation in Parkinson Disease: Behavior and Social Adaptation.
Houeto et al.
Arch Neurol 2006;63:1090-1095.
ABSTRACT
| FULL TEXT
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up
Schupbach et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1640-1644.
ABSTRACT
| FULL TEXT
Parkinson disease, brain volumes, and subthalamic nucleus stimulation
Bonneville et al.
Neurology 2005;64:1598-1604.
ABSTRACT
| FULL TEXT
Subthalamic Stimulation in Parkinson Disease: With or Without Anesthesia?
Maltete et al.
Arch Neurol 2004;61:390-392.
ABSTRACT
| FULL TEXT
|